Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

Featured Releases

January 05, 2026 15:52 ET | Source: SRS Real Estate Partners

SRS Real Estate Partners Significantly Strengthens Industrial Platform with Addition of Strategic San Diego Team

San Diego, CA, Jan. 05, 2026 (GLOBE NEWSWIRE) -- SRS Real Estate Partners announced today the addition of a market-leading industrial team in San Diego, strengthening the firm’s West Coast footprint...
Read More
January 05, 2026 14:56 ET | Source: Dairy Council of California

Dairy Council of California Highlight Milk Safety and Quality Standards for National Milk Day

DCC marks National Milk Day by highlighting the standards and safeguards that protect milk as a safe, nutritious food for families and communities.
Read More

January 05, 2026 16:01 ET | Source: Evolution Metals & Technologies Corp.

Evolution Metals & Technologies Corp. Consummates Business Combination Prior to Trading on NASDAQ

West Palm Beach, FL, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Evolution Metals & Technologies Corp. (“EM&T” or the “Company”), a company focused on building a secure, reliable, and vertically...
January 05, 2026 16:01 ET | Source: Galapagos NV

Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities

Mechelen, Belgium; January 5, 2026, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the works council consultation process regarding the wind-down of cell therapy activities...
January 05, 2026 16:01 ET | Source: Osisko Metals Incorporated

Osisko Metals Appoints COO

Osisko Metals appoints Jeff Hussey as COO.
January 05, 2026 16:01 ET | Source: Cyclerion Therapeutics, Inc.

Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression

Cyclerion & Medsteer entered a strategic agreement to enable the integration of Medsteer's technology and know-how into CYC-126.
January 05, 2026 16:01 ET | Source: Apogee Therapeutics

Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1b Trial of APG777 in Patients with Mild-to-Moderate Asthma and 2026 Anticipated Milestones on January 6, 2026

SAN FRANCISCO and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with potential for...
January 05, 2026 16:01 ET | Source: NewAmsterdam Pharma N.V.

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NAARDEN, the Netherlands and MIAMI, Jan. 05, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...
January 05, 2026 16:00 ET | Source: Portnoy Law

Bgin Blockchain Limited Investigated by the Portnoy Law Firm

LOS ANGELES, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Bgin Blockchain Limited, (“Bgin" or the "Company") (NASDAQ: BGIN) investors that the firm has initiated an investigation...
January 05, 2026 16:00 ET | Source: Cytokinetics, Incorporated

Cytokinetics to Present at the 44th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to...
January 05, 2026 16:00 ET | Source: Mizuho Americas

Mizuho Americas Announces $1 Million in Grants Through the Mizuho USA Foundation

NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Mizuho today announced the Mizuho USA Foundation, the charitable foundation of Mizuho Americas, has awarded $1 million in 2025 grants. With a focus on...
January 05, 2026 16:00 ET | Source: DBV Technologies S.A.

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 (Article 223-16 of the General Regulations of the Autorité des Marchés...

1 2 ...315579